EvolutionaryScale

Name: EvolutionaryScale
Brand: EvolutionaryScale

AI NativeLeader

EvolutionaryScale is an AI research company that provides multimodal protein foundation models (ESM family) and API access via a hosted Forge platform plus an open-weight distribution (ESM3-open) to support protein sequence, structure, and function modeling and generation.

Est 2023|Valuation $1B|Raised $182M|5 Ref Customers

LinkedIn 9K|Web traffic 25K|FTEs 40

MarketsFoundation Models

01Competitive Landscape

| Aspect | EvolutionaryScale (ESM3/Forge) | DeepMind / Isomorphic (AlphaFold ecosystem) | Profluent (generative protein design) | |--------|-------------------------------|--------------------------------------------|--------------------------------------| | Starting Price | Not publicly posted (commercial: contact sales; non-commercial pathways exist) | Not reliably public for enterprise; some access routes are gated | Not publicly posted (generally enterprise/partner-led) | | Recommended For | Teams seeking generative protein foundation models with API access; research-focused groups | Teams focused on structure/complex prediction and structure-centric workflows | Teams seeking protein generation with therapeutics orientation and proprietary platform support | | Key Strength | Multimodal generative protein modeling (sequence/structure/function) and continuity with the ESM research lineage | Strong track record in structure prediction and a broad ecosystem | Therapeutics-oriented platform with wet-lab integration in some offerings | | Key Weakness | Limited public enterprise security/compliance artifacts; unclear commercial pricing; non-commercial licensing constraints on open weights | Primarily structure-centric rather than full generative design for novel functions (depending on the offering); platform access can be restricted | Less transparent independent benchmarking; likely partner dependency | - Direct competitors and their key differentiators - Isomorphic/DeepMind: historically strong at structure prediction and biomolecular modeling, with significant ecosystem impact. - Generate:Biomedicines: closer to end-to-end drug company/platform with wet-lab loops and therapeutic pipelines. - Profluent: focuses on generative protein design and claims fine-grained control at atomic or structural levels. - OpenFold/RoseTTAFold: open/academic alternatives suitable for structure prediction and research workflows. - Feature comparison: where EvolutionaryScale excels vs lags - Excels: - Generative framing and a multimodal approach spanning sequence, structure, and function. - Research credibility stemming from the ESM lineage. - Lags/unclear: - Public enterprise procurement readiness (security attestations, SLAs, audit artifacts). - Standardized public benchmarks against alternatives across diverse tasks. - Pricing comparison: value proposition vs alternatives - Hard to compare due to lack of public pricing across most competitors. - Open alternatives may reduce licensing fees but increase compute and MLOps overhead. - Customer testimonials comparing this product to competitors - Limited direct evidence in public sources about customers switching between these specific vendors. - Market share and adoption trends - There is insufficient reliable public market-share data; adoption is better inferred via research citations, open-source traction (Hugging Face / GitHub activity), and partnerships.

01Competitive Landscape

Aspect	EvolutionaryScale (ESM3/Forge)	DeepMind / Isomorphic (AlphaFold ecosystem)	Profluent (generative protein design)
Starting Price	Not publicly posted (commercial: contact sales; non-commercial pathways exist)	Not reliably public for enterprise; some access routes are gated	Not publicly posted (generally enterprise/partner-led)
Recommended For	Teams seeking generative protein foundation models with API access; research-focused groups	Teams focused on structure/complex prediction and structure-centric workflows	Teams seeking protein generation with therapeutics orientation and proprietary platform support
Key Strength	Multimodal generative protein modeling (sequence/structure/function) and continuity with the ESM research lineage	Strong track record in structure prediction and a broad ecosystem	Therapeutics-oriented platform with wet-lab integration in some offerings
Key Weakness	Limited public enterprise security/compliance artifacts; unclear commercial pricing; non-commercial licensing constraints on open weights	Primarily structure-centric rather than full generative design for novel functions (depending on the offering); platform access can be restricted	Less transparent independent benchmarking; likely partner dependency

Direct competitors and their key differentiators
- Isomorphic/DeepMind: historically strong at structure prediction and biomolecular modeling, with significant ecosystem impact.
- Generate:Biomedicines: closer to end-to-end drug company/platform with wet-lab loops and therapeutic pipelines.
- Profluent: focuses on generative protein design and claims fine-grained control at atomic or structural levels.
- OpenFold/RoseTTAFold: open/academic alternatives suitable for structure prediction and research workflows.
Feature comparison: where EvolutionaryScale excels vs lags
- Excels:
  - Generative framing and a multimodal approach spanning sequence, structure, and function.
  - Research credibility stemming from the ESM lineage.
- Lags/unclear:
  - Public enterprise procurement readiness (security attestations, SLAs, audit artifacts).
  - Standardized public benchmarks against alternatives across diverse tasks.
Pricing comparison: value proposition vs alternatives
- Hard to compare due to lack of public pricing across most competitors.
- Open alternatives may reduce licensing fees but increase compute and MLOps overhead.
Customer testimonials comparing this product to competitors
- Limited direct evidence in public sources about customers switching between these specific vendors.
Market share and adoption trends
- There is insufficient reliable public market-share data; adoption is better inferred via research citations, open-source traction (Hugging Face / GitHub activity), and partnerships.

Aspect

EvolutionaryScale (ESM3/Forge)

DeepMind / Isomorphic (AlphaFold ecosystem)

Profluent (generative protein design)

Starting Price

Not publicly posted (commercial: contact sales; non-commercial pathways exist)

Not reliably public for enterprise; some access routes are gated

Not publicly posted (generally enterprise/partner-led)

Recommended For

Teams seeking generative protein foundation models with API access; research-focused groups

Teams focused on structure/complex prediction and structure-centric workflows

Teams seeking protein generation with therapeutics orientation and proprietary platform support

Key Strength

Multimodal generative protein modeling (sequence/structure/function) and continuity with the ESM research lineage

Strong track record in structure prediction and a broad ecosystem

Therapeutics-oriented platform with wet-lab integration in some offerings

Key Weakness

Limited public enterprise security/compliance artifacts; unclear commercial pricing; non-commercial licensing constraints on open weights

Primarily structure-centric rather than full generative design for novel functions (depending on the offering); platform access can be restricted

Less transparent independent benchmarking; likely partner dependency